Keryx Biopharmaceuticals Inc
KERX
KERX was delisted on the 12th of December, 2018.
153 hedge funds and large institutions have $915M invested in Keryx Biopharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 66 increasing their positions, 40 reducing their positions, and 28 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 40
16% more call options, than puts
Call options by funds: $16.2M | Put options by funds: $13.9M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 157 → 153 (-4)
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
23% less capital invested
Capital invested by funds: $1.19B → $915M (-$271M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$36.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.8M |
| 3 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$9.59M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.02M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$5.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$48.7M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$26.8M |
| 3 |
O
OppenheimerFunds
New York
|
-$12.3M |
| 4 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$12.1M |
| 5 |
DM
Deerfield Management
New York
|
-$9.74M |
KERX Hedge Fund Activity: Q2 2015 in Review
153 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q2 2015, worth a combined $915M — down 23% from $1.19B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of KERX and 24 opened new positions — a net loss of 4 holders — while 40 trimmed existing stakes and 66 added.
The largest buyer was Baupost Group, adding an estimated $36.6M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $48.7M sold.
- 153 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q2 2015, down from 157 in Q1 2015.
- Funds reported $915M of Keryx Biopharmaceuticals Inc stock for Q2 2015, down 23% quarter-over-quarter.
- 24 funds opened new Keryx Biopharmaceuticals Inc positions in Q2 2015 and 28 closed out, a net change of -4 holders.
- The largest Keryx Biopharmaceuticals Inc buyer in Q2 2015 was Baupost Group, an estimated $36.6M added.
- The largest Keryx Biopharmaceuticals Inc seller in Q2 2015 was Sectoral Asset Management, an estimated $48.7M sold.
Based on aggregated 13F filings for Q2 2015.